Last updated on February 2018

Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development


Brief description of study

The goal of this study is to find out which immune molecules, cells, and genes are involved in the development of lymphedema (LE), so that medicines that target them can be considered for treating lymphedema. The hypothesis is that LE is a systemic, autoimmune-like disease that is initiated by inflammatory cytokines induced by surgery, radiation, and possibly chemotherapy in genetically susceptible patients.

Clinical Study Identifier: NCT02949726

Contact Investigators or Research Sites near you

Start Over

Melissa B Aldrich, PhD

The University of Texas Health Science Center at Houston
Houston, TX United States
  Connect »